MENU
+Compare
ATRC
Stock ticker: NASDAQ
AS OF
Jun 12, 04:59 PM (EDT)
Price
$32.34
Change
-$0.69 (-2.09%)
Capitalization
1.45B

ATRC AtriCure Forecast, Technical & Fundamental Analysis

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors... Show more

ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ATRC with price predictions
Jun 11, 2025

ATRC in downward trend: price may decline as a result of having broken its higher Bollinger Band on May 20, 2025

ATRC broke above its upper Bollinger Band on May 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In of the 40 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 10, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ATRC as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ATRC turned negative on June 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for ATRC moved below the 200-day moving average on May 28, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

ATRC moved above its 50-day moving average on May 20, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ATRC crossed bullishly above the 50-day moving average on May 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in of 312 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 252 cases where ATRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.970) is normal, around the industry mean (24.397). P/E Ratio (36.765) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (3.374) is also within normal values, averaging (42.944).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ATRC is expected to report earnings to rise 19.29% to -16 cents per share on August 05

AtriCure ATRC Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Beat
by $0.08
Q4'24
Missed
by $0.13
Q3'24
Beat
by $0.02
Q2'24
Est.
$-0.17
The last earnings report on April 29 showed earnings per share of -14 cents, beating the estimate of -21 cents. With 155.34K shares outstanding, the current market capitalization sits at 1.45B.
A.I. Advisor
published General Information

General Information

a manufacturer of surgical and medical instruments

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
7555 Innovation Way
Phone
+1 513 755-4100
Employees
1200
Web
https://www.atricure.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGIDX13.260.03
+0.23%
Goldman Sachs Global Infras Instl
FSLCX18.83N/A
N/A
Fidelity Small Cap Stock
VMNFX13.52-0.02
-0.15%
Vanguard Market Neutral Inv
PHEFX12.58-0.02
-0.16%
T. Rowe Price Hedged Equity
CAFFX42.59-1.86
-4.18%
American Funds AMCAP 529F1

ATRC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with NVST. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-1.11%
NVST - ATRC
40%
Loosely correlated
+0.47%
IRMD - ATRC
39%
Loosely correlated
+0.11%
SIBN - ATRC
39%
Loosely correlated
-1.52%
ICUI - ATRC
36%
Loosely correlated
-1.71%
MDT - ATRC
36%
Loosely correlated
+0.11%
More